Pirfenidone Improves Familial Idiopathic Pulmonary Fibrosis without Affecting Serum Periostin Levels

Background: Antifibrotic agents have been approved for the treatment of idiopathic pulmonary fibrosis (IPF). However, the efficacy of these drugs in the treatment of familial IPF (FIPF) has not been previously reported. Case presentation: We report the case of a 77-year-old man with FIPF, successful...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicina (Kaunas)
Main Authors: Koga, Yasuhiko, Hachisu, Yoshimasa, Tsurumaki, Hiroaki, Yatomi, Masakiyo, Kaira, Kyoichi, Ohta, Shoichiro, Ono, Junya, Izuhara, Kenji, Dobashi, Kunio, Hisada, Takeshi
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6572615/
https://ncbi.nlm.nih.gov/pubmed/31108995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina55050161
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados